placeholder image
M. Bhave All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study. 
    Journal of Clinical Oncology. 2024
    • Contact
    full name
  • M. Bhave
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration